> top > docs > PubMed:27662822 > annotations

PubMed:27662822 JSONTXT

Annnotations TAB JSON ListView MergeView

sonoma2

Id Subject Object Predicate Lexical cue
T0 4-19 CPA denotes anti-adipogenic
T1 68-74 NEGREG denotes absent
T2 80-85 GENE denotes PCSK9
T3 86-102 NEGREG denotes loss-of-function
T4 103-111 VAR denotes variants
T5 179-232 GENE denotes pro-protein convertase subtilisin/kexin type (PCSK)
T6 180-191 GENE denotes pro-protein
T7 226-230 GENE denotes PCSK
T8 234-250 NEGREG denotes loss-of-function
T9 252-255 NEGREG denotes LOF
T10 257-264 VAR denotes variant
T11 335-342 NEGREG denotes inhibit
T12 349-361 CPA denotes adipogenesis
T13 406-411 GENE denotes e PCS
T14 408-413 GENE denotes PCSK9
T15 414-417 NEGREG denotes LOF
T16 418-426 VAR denotes variants
T17 565-570 NEGREG denotes lower
T18 578-581 NEGREG denotes LOF
T19 619-623 POSREG denotes rose
T20 811-820 NEGREG denotes inhibited
T21 821-833 CPA denotes adipogenesis
T22 914-919 GENE denotes om PC
T23 917-922 GENE denotes PCSK9
T24 927-934 VAR denotes variant
T25 961-973 CPA denotes adipogenesis
T26 1007-1012 GENE denotes om PC
T27 1010-1015 GENE denotes PCSK9
T28 1016-1019 NEGREG denotes LOF
T29 1020-1027 VAR denotes variant
T30 1056-1065 POSREG denotes increases
T31 1084-1098 GENE denotes interleukin-1β
T32 1100-1114 GENE denotes tumor necrosis
T33 1100-1114 DISEASE denotes tumor necrosis
T34 1171-1175 GENE denotes CD36
T35 1217-1222 GENE denotes MCP-1
T36 1248-1257 POSREG denotes increased
T37 1310-1317 NEGREG denotes absence
T38 1321-1343 MPA denotes anti-adipogenic action
T39 1357-1362 GENE denotes PCSK9
T40 1360-1365 GENE denotes K9 LO
T41 1363-1366 NEGREG denotes LOF
T42 1367-1374 VAR denotes variant
T43 1411-1416 GENE denotes PCSK9
T44 1414-1419 GENE denotes K9 in
R4 T6 T10 ThemeOf pro-protein,variant
R5 T7 T10 ThemeOf PCSK,variant
R6 T9 T8 CauseOf LOF,loss-of-function
R7 T9 T11 CauseOf LOF,inhibit
R8 T10 T8 CauseOf variant,loss-of-function
R9 T10 T9 CauseOf variant,LOF
R10 T12 T11 ThemeOf adipogenesis,inhibit
R11 T14 T16 ThemeOf PCSK9,variants
R12 T16 T15 CauseOf variants,LOF
R13 T18 T17 CauseOf LOF,lower
R14 T18 T19 CauseOf LOF,rose
R15 T21 T20 ThemeOf adipogenesis,inhibited
R16 T23 T24 ThemeOf PCSK9,variant
R17 T27 T29 ThemeOf PCSK9,variant
R18 T28 T30 CauseOf LOF,increases
R19 T28 T36 CauseOf LOF,increased
R20 T29 T28 CauseOf variant,LOF
R21 T29 T30 CauseOf variant,increases
R22 T29 T36 CauseOf variant,increased
R23 T31 T30 ThemeOf interleukin-1β,increases
R24 T34 T30 ThemeOf CD36,increases
R25 T35 T30 ThemeOf MCP-1,increases
R0 T2 T4 ThemeOf PCSK9,variants
R1 T3 T1 CauseOf loss-of-function,absent
R2 T4 T1 CauseOf variants,absent
R3 T4 T3 CauseOf variants,loss-of-function
R26 T38 T37 ThemeOf anti-adipogenic action,absence
R27 T38 T41 ThemeOf anti-adipogenic action,LOF
R28 T39 T42 ThemeOf PCSK9,variant
R29 T41 T37 CauseOf LOF,absence
R30 T42 T41 CauseOf variant,LOF

kaiyin_test

Id Subject Object Predicate Lexical cue
T5 4-26 MPA denotes anti-adipogenic effect
T4 68-74 NegReg denotes absent
T1 80-85 Gene denotes PCSK9
T3 86-102 NegReg denotes loss-of-function
T2 103-111 Var denotes variants
T7 234-250 NegReg denotes loss-of-function
T6 257-264 Var denotes variant
T8 335-342 NegReg denotes inhibit
T9 343-361 MPA denotes human adipogenesis
T10 917-922 Gene denotes PCSK9
T28 923-926 NegReg denotes LOF
T12 927-934 Var denotes variant
T13 961-973 MPA denotes adipogenesis
T14 1010-1015 Gene denotes PCSK9
T29 1016-1019 NegReg denotes LOF
T15 1020-1027 Var denotes variant
T17 1056-1065 PosReg denotes increases
T18 1069-1098 MPA denotes mRNA levels of interleukin-1β
T19 1100-1123 MPA denotes tumor necrosis factor-α
T20 1125-1169 MPA denotes sterol regulatory element binding protein-1c
T21 1171-1175 MPA denotes CD36
T22 1310-1317 NegReg denotes absence
T23 1321-1343 MPA denotes anti-adipogenic action
T24 1357-1362 Gene denotes PCSK9
T25 1367-1374 Var denotes variant
T27 1396-1406 PosReg denotes novel role
T26 1438-1450 Interaction denotes interactions
R1 T1 T2 ThemeOf PCSK9,variants
R10 T25 T22 CauseOf variant,absence
R11 T25 T27 CauseOf variant,novel role
R12 T26 T27 ThemeOf interactions,novel role
R13 T10 T12 ThemeOf PCSK9,variant
R14 T12 T28 CauseOf variant,LOF
R15 T13 T28 ThemeOf adipogenesis,LOF
R16 T14 T15 ThemeOf PCSK9,variant
R17 T15 T29 CauseOf variant,LOF
R18 T15 T17 CauseOf variant,increases
R19 T18 T17 ThemeOf mRNA levels of interleukin-1β,increases
R2 T2 T3 CauseOf variants,loss-of-function
R20 T19 T17 ThemeOf tumor necrosis factor-α,increases
R21 T20 T17 ThemeOf sterol regulatory element binding protein-1c,increases
R22 T21 T17 ThemeOf CD36,increases
R3 T3 T4 CauseOf loss-of-function,absent
R4 T5 T4 ThemeOf anti-adipogenic effect,absent
R5 T6 T7 CauseOf variant,loss-of-function
R6 T7 T8 CauseOf loss-of-function,inhibit
R7 T9 T8 ThemeOf human adipogenesis,inhibit
R8 T23 T22 ThemeOf anti-adipogenic action,absence
R9 T24 T25 ThemeOf PCSK9,variant

name_no

Id Subject Object Predicate Lexical cue
T5 4-26 MPA denotes anti-adipogenic effect
T4 68-74 NegReg denotes absent
T1 80-85 Gene denotes PCSK9
T3 86-102 NegReg denotes loss-of-function
T2 103-111 Var denotes variants
T7 234-250 NegReg denotes loss-of-function
T6 257-264 Var denotes variant
T8 335-342 NegReg denotes inhibit
T9 343-361 MPA denotes human adipogenesis
T10 917-922 Gene denotes PCSK9
T28 923-926 NegReg denotes LOF
T12 927-934 Var denotes variant
T13 961-973 MPA denotes adipogenesis
T14 1010-1015 Gene denotes PCSK9
T29 1016-1019 NegReg denotes LOF
T15 1020-1027 Var denotes variant
T17 1056-1065 PosReg denotes increases
T18 1069-1098 MPA denotes mRNA levels of interleukin-1β
T19 1100-1123 MPA denotes tumor necrosis factor-α
T20 1125-1169 MPA denotes sterol regulatory element binding protein-1c
T21 1171-1175 MPA denotes CD36
T22 1310-1317 NegReg denotes absence
T23 1321-1343 MPA denotes anti-adipogenic action
T24 1357-1362 Gene denotes PCSK9
T25 1367-1374 Var denotes variant
T27 1396-1406 PosReg denotes novel role
T26 1438-1450 Interaction denotes interactions
R1 T1 T2 ThemeOf PCSK9,variants
R10 T25 T22 CauseOf variant,absence
R11 T25 T27 CauseOf variant,novel role
R12 T26 T27 ThemeOf interactions,novel role
R13 T10 T12 ThemeOf PCSK9,variant
R14 T12 T28 CauseOf variant,LOF
R15 T13 T28 ThemeOf adipogenesis,LOF
R16 T14 T15 ThemeOf PCSK9,variant
R17 T15 T29 CauseOf variant,LOF
R18 T15 T17 CauseOf variant,increases
R19 T18 T17 ThemeOf mRNA levels of interleukin-1β,increases
R2 T2 T3 CauseOf variants,loss-of-function
R20 T19 T17 ThemeOf tumor necrosis factor-α,increases
R21 T20 T17 ThemeOf sterol regulatory element binding protein-1c,increases
R22 T21 T17 ThemeOf CD36,increases
R3 T3 T4 CauseOf loss-of-function,absent
R4 T5 T4 ThemeOf anti-adipogenic effect,absent
R5 T6 T7 CauseOf variant,loss-of-function
R6 T7 T8 CauseOf loss-of-function,inhibit
R7 T9 T8 ThemeOf human adipogenesis,inhibit
R8 T23 T22 ThemeOf anti-adipogenic action,absence
R9 T24 T25 ThemeOf PCSK9,variant